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ABSTRACT
HIF1 (hypoxia inducible factor 1) is the central reg-
ulator of the cellular response to low oxygen and
its activity is deregulated in multiple human patholo-
gies. Consequently, given the importance of HIF sig-
naling in disease, there is considerable interest in
developing strategies to modulate HIF1 activity and
down-stream signaling events. In the present study
we find that under hypoxic conditions, activation of
the PERK branch of the unfolded protein response
(UPR) can suppress the levels and activity of HIF1
by preventing efficient HIF1 translation. Activation
of PERK inhibits de novo HIF1 protein synthesis by
preventing the RNA-binding protein, YB-1, from inter-
acting with the HIF1 mRNA 5′UTR. Our data indicate
that activation of the UPR can sensitise tumor cells
to hypoxic stress, indicating that chemical activation
of the UPR could be a strategy to target hypoxic ma-
lignant cancer cells.
INTRODUCTION
Cellular hypoxia can occur as a consequence of low at-
mospheric oxygen or locally in tissues due to inflamma-
tion, ischemia, injury or poor vascularisation (1). At the
cellular level, hypoxia is characterised by a switch in en-
ergy metabolism coupled with a rapid change in the tran-
scriptional program, primarily mediated by the hypoxia in-
ducible factor (HIF) family of transcription factors (1,2).
Activation of HIF promotes the expression of specific tar-
get genes that play critical roles in the adaptive response to
hypoxia and the restoration of cellular homeostasis (2).
HIF1 is a ubiquitously expressed heterodimeric tran-
scription factor, composed of an oxygen labile HIF1 sub-
unit and a constitutively expressed HIF1 subunit (2).
HIF1 and HIF1 are essential for development as both
HIF1 and HIF1 knockout mice die in utero between 9.5
and 10.5 days of gestation, largely due to defects in em-
bryonic vascularisation (3–5). HIF1 stability is primarily
regulated through the action of several proline hydroxylases
(PHDs), which act tomodify proline residues in the oxygen-
dependent degradation (ODD) domain of HIF1 (6). Hy-
droxylated HIF1 is recognised by the von-Hippel Lin-
dau (VHL) E3-ubiquitin ligase, which promotes the ubuiq-
uitination and subsequent degradation of HIF1 by the
26S proteasome (7). As a consequence, the half-life of the
HIF1 protein is <5 min in normal conditions, resulting
in the HIF1 protein being virtually undetectable in ade-
quately oxygenated cells and tissues (8,9). In hypoxic cells
PHD enzymes are inhibited resulting in rapid HIF1 ac-
cumulation, this allows HIF1 to dimerise with HIF1 to
promote the expression of HIF target genes (1,2).
Although HIF1 levels are primarily regulated by pro-
teasomal degradation alternative mechanisms exist to mod-
ulate HIF activity such as transcriptional regulation of
HIF genes or post-translational modification of HIF sub-
units (10). Control of HIF1 biogenesis through regula-
tion of protein translation is also emerging as an impor-
tant mechanism for regulating HIF in hypoxic cells. In fact,
HIF1 protein biogenesis is responsible for 40–50% of the
increased levels of HIF1 protein in response to hypoxic
stress (11,12). HIF1 has both 5′ and 3′ UTRs that can reg-
ulate its translation; with the 5′ UTR containing an inter-
nal ribosome entry site that can upregulate HIF1 trans-
lation, and the 3′ UTR mainly responsible for controlling
mRNA stability (13). 5′-UTR-dependent upregulation of
HIF1 translation is observed in metastatic cell lines, in-
dicating that this mechanism of HIF1 elevation may be
critical for the malignant phenotype (13).
In actively growing eukaryotic cells, protein translation
accounts for ∼75% of the total energy expenditure of a cell
(14). During severe hypoxia/anoxia (<0.2% O2), cellular
energy consumption is limited and global protein synthesis
is inhibited through activation of the unfolded protein re-
sponse (UPR) (15). TheUPR is a highly conserved pathway
that allows cells to effectively manage cellular stress trig-
gered by chemical and environmental factors (16). Central
to the UPR is the PKR-like ER kinase (PERK)-dependent
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phosphorylation of eukaryotic initiation factor 2 (eIF2)
which represses global translationwhile promoting the pref-
erential translation of mRNA that encode stress-responsive
factors to restore cellular homeostasis (16,17). During se-
vere hypoxia/anoxia the UPR and hypoxia response path-
ways interact to potentiate the expression of HIF target
genes (18). However, inhibition of the PHD enzymes and
stabilisation of HIF1 occurs at relatively moderate levels
of hypoxia (<2%), which is not sufficient to activate the
UPR (19).
In this present study, we examined the consequences of
activating the UPR in conditions of moderate hypoxia to
investigate if this could potentiate the HIF-dependent hy-
poxic response. Surprisingly, we find that chemical activa-
tion of the UPR during moderate hypoxia impairs HIF1
stabilisation and results in the down regulation of hypoxia-
induced HIF1 activity. Our data indicate that activation of
the UPR in low oxygen severely reduces HIF1 activity by
blocking HIF1mRNA translation in a PERK-dependent
manner. Activation of the UPR reduces the interaction be-
tween the RNA binding protein, YB-1, and the 5′-UTR of
the HIF1mRNA, thus preventing its efficient translation.
Chemical inhibition of PERK rescues theHIF1 defect and
the levels of HIF1 activity in hypoxic cells treated withUPR
agonists. Impairment of the HIF pathway by UPR activa-
tion results in a reduction of cell viability in low oxygen, in-
dicating that targeting the UPR may be a strategy to target
hypoxic malignant cells.
MATERIALS AND METHODS
Cell lines
PC-3 cells were grown in RPMI with 25mM HEPES, sup-
plemented with 10% FBS and L-glutamine. U2OS, MCF7
and COV-434 cells were gown in DMEM supplemented
with 10% FBS, L-gluatamine, and penicillin streptomycin.
U2OS HRE luciferase and U2OS NF-B luciferase cells
have been previously described (20).
Treatments
Cells were incubated at 1% O2 in an in vivo 400 hypoxia
work station (Ruskin, UK). Cells were lysed for protein
extracts, and RNA extraction in the chamber to avoid re-
oxygenation.
Thaspsigargin (Enzo), tunicamycin (Calbiochem),
DMOG (Calbiochem), GSK2606414 (Calbiochem),
MG132 (Sigma), lactacyctin (Calbiochem), ionomycin
(Sigma) were dissolved in DMSO and added to cells at
the concentrations indicated in the figure legends. DTT
(Sigma) and EGTA (Sigma) were prepared in ultrapure
water.
Cell lysis and immunoblotting
Cells were lysed in 8 M urea lysis buffer and immunoblot-
ted as described (21). Antibodies used were HIF1 (Clone
241809, R&D systems), HIF2 (#7096, Cell Signaling
Technologies), phospho- eIF2 (Ser 51) (#9721, Cell Sig-
naling Technologies), eIF2 (#5324, Cell Signaling Tech-
nologies), PERK (#3192, Cell Signaling Technologies),
YB-1 (A303–231A, Bethyl), -tubulin (#2146, Cell Signal-
ing Technologies), VHL (#68547, Cell Signaling Technolo-
gies), -actin (AC-74, Sigma).
Luciferase assays
Lysates for luciferase assay were prepared in 1× passive
lysis buffer (Promega), 100 l per well of a 24-well plate.
10 l of lysate was incubated with 50 l luciferase reagent
(Promega) and measured for 10 s using (Lumat LB9507,
EG&GBerthold). Graphs are represent rawRLUs readings
from three independent experiments.
Polysome profiling
PC-3 cells were grown to 80% confluency and incubated in
100 mg/ml cycloheximide for 3min and resuspended in hy-
potonic polysome extraction buffer (5mMTris [pH 7.5], 2.5
mMMgCl2, 1.5 mMKCl, 1% Triton X-100, 100 mg/ml cy-
cloheximide, 100 U/ml RNasin). Cell were lysed through
the addition of Triton X-100 (0.5%) and sodium deoxy-
cholate (0.5%) to solubilise the cytosolic and endoplasmic
reticulum-associated ribosomes. Extracts were normalised
by OD 260 nm and layered onto 10 ml of 10–50% sucrose
steps and centrifuged at 222 228 × g (36 000 rpm) for 2 h at
4◦C using SW41Ti rotor. The sucrose steps were fraction-
ated into twelve 0.75 ml fractions. Absorbance at OD254 nm
and visualisation by RNA agarose electrophoresis follow-
ing Trizol (Invitrogen) purification was used to determine
the monosomal and polysomal fractions.
RNA immunoprecipitation
To probe for direct interactions between YB-1 protein and
HIF1 transcripts PC-3 were resuspended in hypotonic
polysome extraction buffer and lysed through the addition
of Triton X-100 (0.5%) and sodium deoxycholate (0.5%).
Clarified lysates were incubated with 1 ug of YB-1 antibody
and antibody/protein/RNA complexes were isolated by us-
ing 20 l packed volume protein A sepharose beads. Beads
were washed with polysome extraction buffer andRNA iso-
lated using the PeqGold RNA isolation kit. cDNAwas pre-
pared using Qiagen Quantanova cDNA synthesis kit.
Quantitative reverse transcription-PCR
Quantitative PCR data was generated on a Rotor-Gene
Q (Qiagen) using the following experimental settings:
hold 50◦C for 3 min; hold 95◦C 10 min; cycling (95◦C
for 30 s; 58◦C for 30 s; 72◦C for 30 s with fluores-
cence measurement for 45 cycles). All values were nor-
malised to 18S rRNA or RPL13A levels using the Pfaffl
method as indicated. Primers sequences: HIF1 For- 5′-
CATAAAGTCTGCAACATGGAAGGT-3′, HIF1 Rev
5′-ATTTGATGGGTGAGGAATGGGTT-3′; 18S rRNA
For 5′-GTAACCCGTTGAACCCCATT-3′, 18S rRNA
Rev 5′- CCATCCAATCGGTAGTAGCG- 3′; RPL13A
sense 5′-CCT GGA GGA GAA GAG GAA AGA GA -3′,
antisense 5′-TTG AGG ACC TCT GTG TAT TTG TCA
A-3′; BNIP3 sense 5′-GCC CAC CTC GCT CGC AGA
CAC-3′; GLUT1 sense 5′-CTGGCATCAACGCTGTCT
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TC-3′, antisense 5′-GCC TATGAGGTGCAGGGTC-3′;
PDK1 sense 5′-AGT TCA TGT CAC GCT GGG TA-3′,
antisense 5′-CAG CTT CAG GTC TCC TTG GA-3′.
Cell viability assays
Cell viability was measured using Prestoblue assay (Invit-
rogen) and performed according to the manufacturer’s pro-
tocol. Briefly, PC-3 cells were seeded at a density of 5000
cells/well. Cells were pre-treated with inhibitors for 30 min
before incubation at 1% O2 or 21% O2 for 24 h. The ab-
sorbance was recorded at 570 nm after 30 min incubation
of cells with Presto Blue reagent. The cell viability was ex-
pressed as a percentage relative to untreated controls
RESULTS
ER stress suppresses HIF levels and activity in moderate hy-
poxia
The endoplasmic reticulum (ER) is responsible for per-
forming multiple functions essential for cellular homeosta-
sis, development, and stress responsiveness (22). Severe
hypoxia/anoxia (<0.2% O2) induces ER stress and results
in potent activation of the UPR (23). However, there are
conflicting reports as to whether activation of the UPR dur-
ing moderate hypoxia contributes positively or negatively
to the HIF-dependent transcriptional response (12,24,25).
To examine the effect of activating the UPR on the HIF
response during moderate hypoxic stress (1% O2), PC-3
prostate cancer cells were treated with thapsigargin to in-
duce ER stress (26). Eukaryotic initiation factor 2 (eIF2)
is rapidly phosphorylated in cells treated with thapsigar-
gin, consistent with the UPR being activated (Figure 1A).
Moderate hypoxia (1% O2) was not sufficient to induce the
UPR, as no hypoxia-dependent increase in phospho-eIF2
was observed (Figure 1A). Surprisingly, hypoxia-dependent
HIF1 stabilisation wasmarkedly decreased in hypoxic PC-
3 cells pretreated with thapsigargin compared to controls
(Figure 1A). The effect of thapsigargin on HIF1 stabil-
isation was tested in MCF7 (breast), COV-434 (ovarian)
and U2OS (osteosarcoma) treated with thapsigargin and
exposed to hypoxia. In each of the cell lines tested HIF1
stabilisation was impaired in cells in which the UPR is ac-
tivated indicating that this effect is conserved between cell
lines (Figure 1B–D).
HIF activity was then assessed using U2OS cells con-
taining an integrated luciferase reporter construct possess-
ing three copies of the hypoxia-responsive element (HRE)
consensus-binding site. A robust activation of luciferase ac-
tivity was observed in cells exposed to 1%O2, which was re-
duced by treatment with thapsigargin in a dose-dependent
manner (Figure 1E). Thapsigargin treatment did not alter
TNF-induced NF-B activation, indicating the effect on
HIF activity is specific (Figure 1F).
Previous reports have suggested that modulation of in-
tracellular calcium in hypoxic cells can contribute to HIF-
dependent gene expression, both positively and negatively,
by modulating its levels and/or its activity (12,24,25). As
thapsigargin activates the UPR by significantly altering cal-
cium homeostasis we tested if modulation of intracellu-
lar calcium was sufficient to control HIF1 levels. PC-3
cells pre-treated with the calcium ionophore, ionomycin,
had similar levels of hypoxia induced HIF1 stabilisation
as compared to controls (Supplementary Figure S1A and
B). Similarly, chelating excess calcium using EGTA did
not significantly alter the levels of HIF1 stabilised by low
oxygen (Supplementary Figure S1C). Co-treatment of cells
with thapsigargin and EGTA did not alter the thapsigargin-
dependent inhibition ofHIF1 stabilisation, indicating that
ER stress rather than modulation of calcium homeostasis
alters hypoxia-induced HIF1 levels (Supplementary Fig-
ure S1D).
Activation of the UPR impairs HIF activity
To investigate whether alternative activators of the UPR in-
terfere with HIF activity PC-3 cells were treated with di-
ethiothretol (DTT) or tunicamycin. These agents robustly
activate the UPR with modes of action distinct from one
another, and from thapsigargin (27). DTT and tunicamycin
both activate the UPR, as measured by phospho-eIF2, to
a level similar to that seen following thapsigargin treatment
(Figure 2A–C). Treatment with both DTT and tunicamycin
suppress HIF1 levels following hypoxic stress, consistent
with data from thapsigargin treated cells (Figure 2B and C).
Stabilisation ofHIF1 using the PHD inhibitorsDMOGor
CoCl2 is also sensitive to activation of the UPR, indicating
that UPR-dependent decrease in HIF activity is oxygen in-
dependent (Figure 2D–F, Supplemental Figure S2). HIF1
levels and activity were also compromised in U2OS HRE-
Luc cells pre-treated with UPR activators and exposed to
hypoxia or DMOG, consistent with results from PC-3 cells
(Figure 2G–L).
Activation of the UPR does not alter HIF1 protein stability
HIF1 protein levels are primarily controlled by ubiquitin-
mediated proteolysis (2). Previous work has indicated that
inducing ER stress through modulation of calcium levels
can interfere with the ubiquitin-mediated degradation of
HIF1 (28). However, treatment with the proteasome in-
hibitor, MG132, did not significantly increase HIF1 lev-
els in thapsigargin treated cells indicating thapsigargin is
not acting to modulate HIF1 protein stability (Supple-
mental Figure S3A and B). HIF1 could not be stabilised
with MG132, or an alternative proteasome inhibitor, lac-
tacystin, in the presence of thapsigargin, suggesting that
UPR-dependent modulation of HIF1 is independent of
proteasomal degradation (Supplemental Figure S3C and
D). HIF1 protein levels can also be modulated by au-
tophagic degradation (29), however lysosome inhibitors
failed to rescue the levels of HIF1 in thapsigargin treated
PC-3 cells, indicating UPR-dependent control of HIF1 is
independent of this signaling pathway (Supplemental Fig-
ure S3E and F). Together these data indicate that UPR ac-
tivation does not modulate HIF1 levels by altering HIF1
protein stability.
Activation of the UPR reduces HIF1 translation
Levels and activation of HIF can be altered by transcrip-
tional control of HIF subunits (2). However, steady state
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Figure 1. Reduction of HIF1 accumulation and activity in thapsigargin treated cells. (A) PC-3, (B) U2OS, (C) MCF7 or (D) COV-434 cells were treated
with 50nM thapsigargin as indicated and exposed to 1% O2 for the indicated times. Whole-cell lysates (WCLs) prepared from these cells were subjected to
immunoblot analysis to assess expression levels of the indicated proteins. (E) U2OS cells stably expressing luciferase driven from theHREpromoter element
(HRE-Luc) were treated with the indicated concentrations of thapsigargin and exposed to 1% O2 for 7 h. (F) U2OS cells stably expressing luciferase driven
from the NF-B promoter element (B-Luc) were treated with the indicated concentrations of thapsigargin and stimulated with TNF for 7 h. Results
presented represent the mean plus S.D. of three experiments. Values in E and F are normalised to the respective untreated control.
levels of HIF1 mRNA are unaltered by treatment with
thapsigargin, hypoxia or hypoxia mimetics as indicated by
qRT-PCR analysis of HIF1 mRNA levels (Figure 3A,
B, Supplemental Figure S4A–E). HIF1 mRNA associ-
ated with active ribosomes was measured to determine the
rate of HIF1 mRNA translation. Cellular protein synthe-
sis, as well as translation rates of individual mRNAs, can
be measured by polysome profiling; a technique in which
free ribosomes can be separated from mRNA bound ribo-
somes (polysomes) on a sucrose gradient. Hypoxia results
in a moderate decrease in the translation rates in PC-3 cells
as indicated by the increase in the number of monosomes
detected in cells exposed to 1% O2 (Figure 3C). The de-
crease in global translation rates is independent of HIF ac-
tivity, as the hypoxia mimetic, DMOG, has no significant
effect on protein synthesis (Figure 3D). Surprisingly, acti-
vation of the UPR using thapsigargin did not significantly
alter the global translation rates as measured by the num-
ber of actively translating ribosomes (polysomes) in either
hypoxic or DMOG treated cells (Figure 3C and D, Sup-
plemental Figure S5). To investigate the levels of individ-
ual mRNAs associated with actively translating ribosomes,
cDNAswere prepared from fractions containing polysomes
(Fractions 8–11) (Figure 3C, D and Supplemental Figure
S3). Quantitative RT-PCR analysis of polysome-associated
HIF1 mRNA revealed a reduction of actively translating
HIF1 in thapsigargin treated samples in both hypoxic and
DMOG treated cells (Figure 3E and F). These data suggest
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Figure 2. Activation of the UPR reduces the accumulation of HIF1 and HIF1 activity in response to hypoxia or PHD inhibition. PC-3 cells treated with
(A) 50 nM thapsigargin, (B) 2 mM DTT, (C) 2.5 g/ml tunicamycin were subsequently exposed to 1% O2 for 3 h. WCLs prepared from these cells were
subjected to immunoblot analysis to assess expression levels of the indicated proteins. PC-3 cells treated with (D) 50 nM thapsigargin, (E) 2 mMDTT, (F)
2.5 g/ml tunicamycin were subsequently treated with 1 mM DMOG for 3 h. WCLs prepared from these cells were subjected to immunoblot analysis to
assess expression levels of the indicated proteins. WCLs and luciferase activity was measured from U2OS cells stably expressing HRE-luciferase treated
with (G, J) 50 nM thapsigargin, (H, K) 2mM DTT or (I, L) 2.5 g/ml tunicamycin and subsequently exposed to 1% O2 (G–I) 1mM DMOG (J–L) for 7
h, as indicated. WCLs were resolved by SDS PAGE and analysed by immunoblot using the indicated antibodies. HRE luciferase results are raw luciferase
values and represent the mean plus S.D. of three experiments.
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Figure 3. Activation of the UPR suppresses translation of HIF1 mRNA. Quantitative RT–PCR analysis of HIF1 mRNA prepared from PC-3 cells
treated with thapsigargin (50 nM) and (A) 1%O2 or (B) DMOG (1 mM) as indicated. Values are normalised to 18S rRNA and fold change calculated from
control samples prepared from untreated cells. Representative polysome profiles of PC-3 cells treated with thapsigargin (50 nM) and exposed to (C) 1%
O2 or (D) DMOG (1 mM) for 7 h. Fractions containing monosomes and polysomes are indicated on the graph. Quantitative RT-PCR analysis of HIF1
mRNA prepared from polysomal fractions (8–11) prepared from PC-3 cells treated with thapsigargin (50 nM) and exposed to (E) 1% O2 or (F) DMOG (1
mM) as indicated. All values are normalised to 18S rRNA and fold change calculated from control samples prepared from untreated cells. Significance was
calculated relative to untreated control using a one-way ANOVA with Dunnett’s multiple comparisons test.
that HIF1 mRNA translation is sensitive to activation of
the UPR.
UPR-dependent suppression of HIF activity requires PERK
eIF2 is phosphorylated on S51 by four distinct kinases;
PERK, heme-regulated inhibitor (HRI), protein kinase R
(PKR), and general control non-depressible 2 (GCN2)
which are activated by ER-stress, heme depletion, viral in-
fection and amino acid starvation, respectively (30). Inhi-
bition of PERK using GSK 2606414, a small molecule in-
hibitor, prevented thapsigargin-induced eIF2 phosphory-
lation consistent with the induction of ER stress (Figure
4A). Immunoblot analysis demonstrated that PERK inhi-
bition reversed thapsigargin-dependent reduction ofHIF1
levels (Figure 4A). Inhibition of PERK rescued the HIF1
defect from both hypoxic and DMOG treated cells exposed
to DTT and tunicamycin (Figure 4B–F). PERK inhibi-
tion alone did not increase HIF1 levels in hypoxic cells,
suggesting it is acting to reverse inhibition, rather than
as a direct activator (Supplemental Figure S6). Inhibition
of PERK was also sufficient to restore HIF1 levels in
U2OS HRE-Luc cells exposed to UPR agonists (Figure
5A–F). Treatment with PERK inhibitor alone was not suf-
ficient to elevate HIF1 levels or activity in the absence
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Figure 4. The UPR suppresses hypoxia-dependent HIF1 stabilisation in a PERK-dependent manner. PC-3 cells treated with (A,D) thapsigargin (50 nM)
(B, E) DTT (2 mM) (C, F) 2.5 g/ml tunicamycin and exposed to either (A–C) 1% O2, or (D–F) 1 mM DMOG for 3 h, were treated with the PERK
inhibitor, GSK2606414 (0.3 M) as indicated. WCLs were resolved by SDS PAGE and analysed by immunoblot using the indicated antibodies.
of UPR agonists (Supplemental Figure S6). Importantly,
treatment with UPR agonists, either alone or in combi-
nation with GSK2606414 did not significantly alter lev-
els of TNF induced NF-B activity; indicating that UPR-
dependent changes in HIF activity are specific (Supplemen-
tal Figure S7A–D). Together these results demonstrate that
activation of the UPR inhibits HIF signaling in a PERK-
dependent manner.
UPR-dependent suppression of HIF-target genes is reversed
by PERK inhibition
To examine the role of the UPR on the expression of
hypoxia-responsive genes, we performed quantitative real
time PCR analysis of the expression of HIF1 target genes in
PC-3 and U2OS cells treated with thapsigargin. PC-3 and
U2OS cells were treated with thapsigargin and the PERK
inhibitor and subjected to hypoxia for 7 h (Figure 6A and
B). RNA was isolated from these cells and was used to
quantitate the transcript levels of the canonical HIF1 target
genes; CAIX, GLUT1 and PDK1. As expected, exposure
to low oxygen resulted in an increase in expression of all of
these genes, as compared to control (Figure 6A and B). Ex-
pression of HIF target genes is suppressed in hypoxic cells
treated with thapsigargin and inhibition of PERK was suf-
ficient to reverse the UPR-dependent suppression of HIF-
responsive genes in both PC-3 and U2OS cells (Figure 6A
and B).
PERK Inhibition rescues HIF1 translation in thapsigargin
treated cells
Polysomal profiling was performed on PC-3 cells treated
with thapsigargin and GSK2606414 to measure actively
translating ribosomes. Surprisingly, PERK inhibition did
not have an obvious effect on global protein synthesis, as
measured by the number of actively translating ribosomes
in hypoxic orDMOG treated cells (Figure 7A andB). Treat-
ment with GSK2606414 did however significantly reverse
the thapsigargin-dependent suppression of HIF1 mRNA
translation in both hypoxic and DMOG treated PC-3, indi-
cating that the UPR-dependent decrease in HIF1 transla-
tion is in part dependent on PERK activity (Figure 7C and
D).
HIF1 mRNA/YB-1 interaction is disrupted in thapsigargin
treated cells
Maintaining high levels of HIF1 mRNA translation is
critical for full activation of HIF during prolonged hypoxia
(11,12). Several regulatory factors have been identified that
enhance or reduce HIF1 translation by directly binding to
HIF1 mRNA. One such factor is the Y-box binding pro-
tein 1 (YB-1) that binds directly to the 5′ UTR of HIF1
mRNA to sustain high levels of HIF1 in hypoxia (31).
Previous studies have reported YB-1 activity and subcel-
lular localisation is sensitive to conditions of ER-stress.
YB-1, normally diffusely present in the cytosol, relocalises
to ribonucleoprotein complexes known as stress granules
in thapsigargin treated cells (32). We therefore examined
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Figure 5. Inhibition of PERK rescues UPR-dependent suppression of HIF transcriptional activity. WCLs were prepared and luciferase activity was mea-
sured from U2OS cells stably expressing HRE-luciferase treated with (A, D) 50 nM thapsigargin, (B, E), 2 mMDTT or (C, F) 2.5 g/ml tunicamycin and
subsequently exposed to 1% O2 (A–C) 1 mM DMOG (D–F) for 7 h in the presence of the PERK inhibitor GSK2606414 (0.3 M) as indicated. WCLs
were resolved by SDS PAGE and analysed by immunoblot using the indicated antibodies. HRE luciferase results represent the mean plus S.D. of three
independent experiments.
whether YB-1 played a role in UPR-dependent reduction
in HIF1 translation. As the total levels of YB-1 are not
altered by either hypoxia or activation of the UPR (Figure
8A), we investigated if the YB-1/ HIF1 mRNA was dis-
rupted by thapsigargin treatment. YB-1 was efficiently pre-
cipitated from cell extracts using a specific polyclonal an-
tibody (Supplemental Figure S8A). cDNA prepared from
YB-1 precipitates and analysed by quantitative RT-PCR
revealed an increased association between YB-1 and the
HIF1 transcript, consistent with its role in maintaining
HIF1 translation in low oxygen (Figure 8B). In the pres-
ence of the UPR agonist, thapsigargin, the levels of YB-
1 associated with the HIF1 transcript are reduced (Fig-
ure 8C). The reduction in the YB-1 / HIF1 mRNA in-
teraction is consistent with the reduction in HIF1 trans-
lation. YB-1 interaction with HIF1 mRNA was specific
as no significant binding of the IL-8 transcript to YB-1
was observed (Supplemental Figure S8B). Thapsigargin-
dependent reduction of the YB-1/ HIF1 mRNA interac-
tion was partially reversed byGSK2606414, consistent with
the increase in HIF1 translation (Figure 8C). Our data in-
dicate that activation of the UPR reduces the interaction
between the translational activator YB-1 and the HIF1
mRNA in a PERK-dependent manner.
Thapsigargin sensitises cells to hypoxic stress
Activation of the HIF family of transcription factors is a
critical component of the cellular response to lowoxygen. In
solid tumor cells elevated levels of HIF1 contribute to the
malignant phenotype by promoting the expression of pro-
angiogenic and pro-survival gene products. As thapsigargin
decreases HIF1 levels and activity we examined if prostate
cancer cell lines were more sensitive to thapsigargin in hy-
poxic cells. PC-3 cells were treated with thapsigargin and
incubated at normoxia and hypoxia for 24 h. The viability
of hypoxic PC-3 cells was significantly reduced by thapsigar-
gin treatment, consistent with the reduction ofHIF1 activ-
ity (Figure 9A). Increased sensitivity to thapsigargin in low
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Figure 6. Inhibition of PERK rescues UPR-dependent suppression of HIF-target genes. (A) Quantitative RT–PCR analysis of CAIX, Glut1 and PDK1
mRNA prepared from PC-3 cells treated with 50 nM thapsigargin and 0.3 M GSK2606414 as indicated, and exposed to 1% O2 for 7 h. All values are
normalised to RPL13A mRNA and fold change calculated from control samples prepared in normoxic conditions. (B). Quantitative RT–PCR analysis of
CAIX, Glut1 and PDK1 mRNA prepared fromU2OS cells treated with 50 nM thapsigargin and 0.3 MGSK2606414 as indicated and exposed to 1% O2
for 7 h. All values are normalised to RPL13A mRNA and fold change calculated from control samples prepared in normoxic conditions. Significance was
calculated relative to hypoxic controls using a one-way ANOVA with Dunnett’s multiple comparisons test.
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Figure 7. UPR-dependent suppression of HIF1 translation in attenuated by PERK. Representative polysome profiles of PC-3 cells treated with 50 nM
thapsigargin and 0.3 M GSK2606414 and exposed to (A) 1% O2 or (B) 1 mM DMOG for 7 h. Fractions containing monosomes and polysomes are
indicated on the graph. Quantitative RT-PCR analysis of HIF1mRNA prepared from polysomal fractions (8–11) prepared from PC-3 cells treated with
50 nM thapsigargin and 0.3 M GSK2606414 then exposed to (C) 1% O2 or (D) 1 mM DMOG for 7 h as indicated. All values are normalised to 18S
rRNA and fold change calculated from control samples prepared from hypoxic or DMOG treated cells. Significance was calculated relative to untreated
control using a one-way ANOVA with Dunnett’s multiple comparisons test.
oxygen conditions was specific, as normoxic and hypoxic
PC-3 cells were equally sensitive to the antimitotic agent,
docetaxel (Figure 9B). The data suggest that activation of
the UPR reduces the HIF-dependent hypoxic response by
impairing HIF1 mRNA translation.
DISCUSSION
Clinical and experimental data suggest that oxygen home-
ostasis and HIF activity is disrupted in multiple human
pathologies such as heart disease, cancer, cardio vascular
disease and chronic obstructive pulmonary disease (1,33).
The majority of studies examining how HIF is deregulated
have focused on protein stability, however control of HIF1
translation remains relatively understudied despite its ma-
jor contribution to the HIF-dependent hypoxic response.
The results from the present study indicate that activation of
the UPR during moderate hypoxia can attenuate the HIF-
dependent transcriptional program. UPR agonists prevent
the full activation of HIF by inhibiting HIF1 mRNA
translation, resulting in a decrease in HIF1 transcriptional
activity and a suppression of HIF1-target gene expression
in a variety of cell lines.
The UPR is a major determinant of cell survival in
response to various conditions of cellular stress and is
associated with various human pathologies including in-
flammatory diseases, diabetes and cancer (22). The UPR
is characterised by the activation of three parallel sig-
nalling pathways: PERK-dependent phosphorylation of
eIF2, inositol-requiring protein 1 (IRE1)–X-box bind-
ing protein 1 (XBP1) and activating transcription factor 6
(ATF6). Our data indicate that activation of the PERK
pathway suppresses the full activation of HIF target gene
expression. Polysome profiling suggests that HIF1mRNA
translation is extremely sensitive to UPR activation. These
data were unexpected, as HIF1 is efficiently stabilised in
severely hypoxic cells in which the UPR is activated (23).
Our results indicate that activation of the UPR does not
promote HIF1 accumulation, but severely suppresses it,
indicating that alternative signaling pathways must be ac-
tivated to maintain HIF1 biogenesis in severely hypoxic
cells. Interestingly, our data show that hypoxia-dependent
accumulation of HIF2 is unaffected by UPR activation,
suggesting the translational control of HIF1 mRNA by
YB-1 is specific for the HIF1 subunit (Figure 8A).
Accumulating evidence indicates HIF1 translation is
an important mechanism to control HIF activity in cells
(11,12). HIF1mRNA has non-coding regions at both the
5′ and 3′ ends of the transcript that can be bound by regula-
tory proteins to control rates of HIF1 biogenesis (31,34).
However, the signaling pathways that regulate their binding
to the HIF1 transcript remain poorly defined (31,34). YB-
1 is a multifunctional nucleic acid-binding protein that can
directly bind to and activate translation of HIF1 mRNA
to promote sarcoma cell invasion and enhanced metastatic
capacity in vivo (31). In our present study we find that ac-
tivation of the UPR under conditions of hypoxic stress re-
duces the interaction of YB1 with HIF1mRNA, reducing
HIF1mRNA translation and causes a decrease in HIF1
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Figure 8. Activation of the UPR suppresses HIF1 translation by preventing YB-1 binding to HIF1 mRNA. (A) WCLs were prepared from PC-3 cells
treated with thapsigargin, 0.3 M GSK2606414 and exposed to 1% O2 as indicated. WCLs were resolved by SDS PAGE and analysed by immunoblot
using the indicated antibodies. (B) HIF1 mRNA bound to YB-1 as measured by qRT-PCR following YB-1 immunoprecipitation. (C) HIF1 mRNA
bound to YB-1 in the presence of 1% O2, 50 nM thapsigargin and 0.3 M GSK2606414 as indicated. RNA IP values are normalised against inputs and
presented as means ± SD. Significance was calculated relative to untreated control using a one-way ANOVA using the Dunnett multiple comparison test.
Figure 9. Activation of the UPR sensitises cells to hypoxic stress. (A) PC-3 cells were treated with 100nM thapsigargin and incubated for 24 h in 1% or
21% O2. Cell viability was measured by prestoblue assay and values normalised to untreated controls. (B) As in (A) with 100 nM Docetaxel. Significance
was calculated relative to untreated control using an unpaired t-test.
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levels. Total YB-1 is not altered by activation of the UPR
or hypoxic stress, however when cells experience ER stress
YB-1 alters its subcellular distribution to localise to stress
granules; discrete riboprotein complexes in the cytoplasm
of cells (32). This rapid redistribution of YB-1 results in less
YB-1 being associated with HIF1mRNA, suppressing its
translation.
In addition to its role in ER homeostasis, the UPR has
emerged as a key mediator of DNA replication, energy
metabolism and cellular activation of apoptosis (35,36).
UPR components are often deregulated in malignant cells
and the activation of the UPR is thought to contribute to
tumor development (37). However, whether activation of
the UPR is positive or negative for tumor progression re-
mains unclear (38,39). UPR agonists such as thapsigargin
and tunicamycin have been shown to be effective in pro-
moting tumor cell death (40,41). Indeed, analogues of thap-
sigargin are currently in clinical trials as prostate cancer
therapeutics (42). The effectiveness of these agents in tar-
geting tumor cells may be due to their ability to target the
HIF pathway. Indeed, histological analysis of implanted tu-
mors in nude mice treated with tunicamycin revealed re-
duced growth, vasculature and VEGF levels, classical signs
of reduced HIF activity (43). Our data suggest that hypoxic
tumor cells display increased sensitivity to UPR agonists,
indicating that activation of the UPR may be a strategy to
target hypoxic, solid tumors.
Collectively our data reveal that ER-stress regulates the
interaction between the YB-1 protein and HIF1 mRNA,
which can alter rates of HIF1 protein synthesis. UPR-
dependent suppression of HIF1may provide a novel strat-
egy for targeting aberrant HIF activity in human disease.
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